NumerixS Investment Technologies Inc - ACHILLION PHARMACEUTICALS IN ownership

ACHILLION PHARMACEUTICALS IN's ticker is ACHN and the CUSIP is 00448Q201. A total of 130 filers reported holding ACHILLION PHARMACEUTICALS IN in Q2 2017. The put-call ratio across all filers is 1.19 and the average weighting 0.1%.

Quarter-by-quarter ownership
NumerixS Investment Technologies Inc ownership history of ACHILLION PHARMACEUTICALS IN
ValueSharesWeighting
Q1 2018$29,000
-76.6%
7,796
-81.9%
0.01%
-75.0%
Q4 2017$124,000
-1.6%
43,096
+57.4%
0.03%
+47.4%
Q2 2017$126,000
-61.0%
27,383
-64.3%
0.02%
-48.6%
Q1 2017$323,000
+107.1%
76,783
+103.1%
0.04%
+85.0%
Q4 2016$156,000
-47.8%
37,800
+2.4%
0.02%
-48.7%
Q3 2016$299,000
+1561.1%
36,900
+1504.3%
0.04%
+1850.0%
Q2 2016$18,000
-94.9%
2,300
-94.2%
0.00%
-95.7%
Q2 2015$350,00039,5000.05%
Other shareholders
ACHILLION PHARMACEUTICALS IN shareholders Q2 2017
NameSharesValueWeighting ↓
MAK CAPITAL ONE LLC 5,191,600$8,255,0004.47%
RTW INVESTMENTS, LP 13,749,383$21,862,0002.04%
ARMISTICE CAPITAL, LLC 4,300,000$6,837,0000.52%
DAFNA Capital Management LLC 630,182$1,002,0000.50%
Rock Springs Capital Management LP 2,325,000$3,697,0000.18%
683 Capital Management, LLC 1,000,000$1,590,0000.10%
Alambic Investment Management, L.P. 133,698$213,0000.09%
South Dakota Investment Council 3,037,004$7,310,0000.08%
Alpine Global Management, LLC 205,172$326,0000.08%
Rhenman & Partners Asset Management AB 402,800$640,0000.07%
View complete list of ACHILLION PHARMACEUTICALS IN shareholders